Phase III randomized placebo-controlled trial of two doses of megestrol acetate as treatment for menopausal symptoms in women with breast cancer: Southwest Oncology Group Study 9626. (Q46674528)
Jump to navigation
Jump to search
scientific article published in April 2008
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase III randomized placebo-controlled trial of two doses of megestrol acetate as treatment for menopausal symptoms in women with breast cancer: Southwest Oncology Group Study 9626. |
scientific article published in April 2008 |
Statements
1 reference
Phase III randomized placebo-controlled trial of two doses of megestrol acetate as treatment for menopausal symptoms in women with breast cancer: Southwest Oncology Group Study 9626. (English)
1 reference
Scott M Lippman
1 reference
J Wendall Goodwin
1 reference
Stephanie J Green
1 reference
Carol M Moinpour
1 reference
James D Bearden
1 reference
Jeffrey K Giguere
1 reference
Caroline S Jiang
1 reference
Silvana Martino
1 reference
Kathy S Albain
1 reference
1 April 2008
1 reference
1 reference
26
1 reference
10
1 reference
1650-1656
1 reference
Identifiers
1 reference
1 reference